Announcement of private placement completion

EZZ Life Science Holdings Limited (ASX: $EZZ) has successfully completed a private placement, raising $854,100 with strategic investor, Kingstone Venture Capital Pty. Ltd. The funds raised will be utilized to enhance EZZ's distribution channels, targeting expansion into new markets including Korea, Japan, and Southeast Asia.

Executive commentary on private placement and strategic investor

The completion of the private placement with Kingstone Venture Capital Pty. Ltd marks a significant milestone for EZZ Life Science. The funds raised will enable us to strengthen our distribution channels and facilitate our expansion into new markets, particularly in Korea, Japan, and Southeast Asia. We are excited about the expertise and experience that Kingstone VC and its management bring in the e-commerce and omnichannel space, which will be invaluable as we pursue our growth strategy.

Summary of private placement completion and outlook

EZZ Life Science Holdings has successfully completed a private placement, raising $854,100 with strategic investor, Kingstone Venture Capital Pty. Ltd. The funds will be used to enhance distribution channels and target expansion into new markets, including Korea, Japan, and Southeast Asia. The company aims to finalize a formal distribution agreement with Kingstone VC by the close of this financial year. The strategic investment and partnership with Kingstone VC, known for its expertise in household consumer brands, is expected to bolster EZZ's position in the targeted markets. This move aligns with EZZ's mission to improve quality of life and human health through the development and distribution of high-quality health and wellness products. The company's focus on research and development in gene technology to address key human health challenges demonstrates its commitment to driving ongoing growth and innovation in the consumer health sector.